Drug news
Approval letter from FDA for Augment Bone Graft- Wright Medical
Wright Medical Group, Inc. announced that its BioMimetic subsidiary has received an Approvable Letter from the FDA for its Premarket Approval Application (PMA) for Augment Bone Graft. The approvable letter indicates that FDA determined Augment Bone Graft to be safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications and is approvable subject to customary preapproval facilities inspections.
Wright medical has also announced its intention to merge with Tornier N.V.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.